Breaking News
Get 40% Off 0
💰 Ray Dalio just increased his holdings in Google by 162.61% - See the full portfolio with InvestingPro’s free Stock Ideas tool Copy Portfolios
Close

TC BioPharm Holdings PLC (TCBP)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow TC BioPharm Holdings's earnings

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
1.1297 -0.0203    -1.77%
- Real-time Cboe. Currency in USD ( Disclaimer )
Type:  Equity
Market:  United States
  • Volume: 308,088
  • Bid/Ask: 0.0000 / 0.0000
  • Day's Range: 1.1100 - 1.1700
TC BioPharm Holdings 1.1297 -0.0203 -1.77%

TC BioPharm Holdings PLC Company Profile

 
Get an in-depth profile of TC BioPharm Holdings PLC, including a general overview of the company's business and key management, as well as employee data and location and contact information.
IndustryBiotechnology & Medical Research
SectorHealthcare
Employees

60

Equity Type

ORD

TC Biopharm (Holdings) Plc, a clinical-stage biopharmaceutical company, focuses on the development of immunotherapy products based on its allogeneic gamma delta T cell platform. Its product pipeline includes OmnImmune, an allogeneic unmodified gamma-delta T cell therapy product under Phase 2/3 trails for the treatment of acute myeloid leukemia; and ImmuniStim, an unmodified cell therapy to treat viral infections as well as cancers. The company was founded in 2013 and is headquartered in Motherwell, the United Kingdom.

Contact Information

Address Maxim 1 2 Parklands Way
Holytown Motherwell, ML1 4WR
United Kingdom
Phone 44 14 1433 7557
Fax -

Top Executives

Name Age Since Title
Arlene M. Morris 71 2022 Non-Executive Independent Chair
Bryan L. Kobel 42 2021 CEO & Director
Edward Z. Niemczyk 43 2022 Non-Executive Independent Director
James Culverwell 66 2022 Non-Executive Independent Director
Isabelle Riviere - 2022 Member of Scientific Advisory Board
Martin E. Thorp 71 2016 CFO & Director
Mark L. Bonyhadi 70 2022 Chairman of Scientific Advisory Board & Non-Executive Independent Director
Uma Lakshmipathy - 2022 Member of Scientific Advisory Board
Daniel Olive - 2022 Member of Scientific Advisory Board
Blythe Sather - 2022 Member of Scientific Advisory Board
Erin Adams - 2022 Member of Scientific Advisory Board
Chris Bond - 2022 Member of Scientific Advisory Board
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

TCBP Comments

Write your thoughts about TC BioPharm Holdings PLC
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Mesut Sorulmaz
Mesut Sorulmaz Dec 14, 2023 2:53PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Bu daha nereye cokecek 0.15 maliyet ama 5 den 7 den alana ayip
Richard Tantamco
Richard Tantamco Nov 25, 2022 9:10AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Lost evrything here… not sure if leaving the stocks will make a difference
John Berry
John Berry Aug 10, 2022 6:17PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Gap to fill to .60 cents. I called PDSB doubled from $2.90 to $5.68 in 6 weeks. Start listening people
Aderson Isaac
Aderson Isaac Aug 10, 2022 6:17PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
I love this stock
John Berry
John Berry Aug 09, 2022 10:28PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Load up
Abubaka mavosuru
Abubaka mavosuru Mar 02, 2022 2:20PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
this is a very good stock 👍
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email